Medical Xpress news
Medical Xpress / Brain-penetrating nanoparticles, ultrasound and microbubbles show promise in treating glioblastoma
University of Virginia Comprehensive Cancer Center scientists have developed a promising new experimental approach to targeting glioblastoma, the most common and deadliest brain cancer. The approach could overcome many of ...
Medical Xpress / GLP-1 diabetes drugs linked to up to 68% higher hair loss risk
The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, a study published by The BMJ finds. ...
Medical Xpress / Singing therapy provides symptom relief and greater quality-of-life for people with chronic belching
A new randomized clinical trial suggests that singing therapy may provide a more effective and engaging treatment option than standard breathing exercises for people with supragastric belching, a chronic gastrointestinal ...
Medical Xpress / Same carcinogen, different tumors: Mouse study reveals the role of genetic background
Why do cancers develop differently in different people—even when they are exposed to the same risk factors? An international research group, including the German Cancer Research Center (DKFZ), has demonstrated in mice that ...
Medical Xpress / Data analysis shows no increase in mental health prescriptions after abortion
While more women globally are using medication to have abortions, a University of Maryland-led study published today in JAMA Psychiatry found no evidence that a first medication or procedural abortion caused an increase in ...
Medical Xpress / Human study links reduced inflammation to later myopia onset
University of Oklahoma College of Medicine researcher Jody Summers, Ph.D., has long hypothesized that inflammation plays a role in the development of myopia, or nearsightedness, in which close-up vision is clear but distance ...
Medical Xpress / New therapeutic target expands options for multiple myeloma
In a phase 1 clinical trial, treatment with the investigational bispecific antibody cevostamab reduced cancer in more than 40% of patients with multiple myeloma, many of whom had already undergone multiple other cancer treatments, ...
Medical Xpress / Large national study finds differences in multiple sclerosis death rates by age, race and geography
An analysis of more than 42,000 U.S. deaths linked to multiple sclerosis (MS) found that death rates varied by age, geography, race and ethnicity, with Black patients dying younger than white patients and high blood pressure ...
Medical Xpress / Immune changes emerge up to 10 years before inflammatory bowel disease diagnosis
Researchers at the Icahn School of Medicine at Mount Sinai have identified immune system changes that can be detected up to 10 years before inflammatory bowel disease (IBD) develops, offering new insight into how the disease ...
Medical Xpress / Two cellular components unlock maturation in human leukemia cells, study finds
In leukemia's most aggressive forms, the blood cell factories in our bone marrow falter. Instead of dividing and multiplying at their usual prolific pace, generating hundreds of billions of new cells daily, some precursor ...
Medical Xpress / How p53 mutations drive immunotherapy resistance—and a path to overcome it
Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, but many tumors remain resistant. A new study from researchers at the Hackensack Meridian Center for Discovery and Innovation (CDI) identifies a previously ...
Medical Xpress / Mental health treatment for serious offenders could reduce harm to society and save money
Prisoners convicted of serious violent offenses were found to be less aggressive and less likely to reoffend following a mental health intervention that could save money and reduce harm to society, according to new research ...
